drugset / Trial / NCT00594139

Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence

NCT00594139 ↗

Phase 2 Withdrawn Tengion
NaSingle-groupOpen-labelTreatment

Summary

Subjects with non-neurogenic over-active bladder will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will increase functional capacity and thereby reduce the number of micturition episodes per day in subjects with non-neurogenic over active bladder and urge predominant incontinence.

Timeline

Start
2008-01
Primary completion
2008-01
Completion
2008-01

Outcome

Outcome not reported

Stopped: “Reprioritization of study programs”

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous neobladder construct Unknown — —

Indications